Glucocorticoids

Rheumatoid arthritis ( RA ), along with glucocorticoid use, is associated with cardiovascular disease. Cardiovascular safety of glucocorticoids in rheumatoid...


An update of the European League Against Rheumatism ( EULAR ) rheumatoid arthritis management recommendations to account for the most...


The FDA ( Food and Drug Administration ) has granted accelerated approval to Xpovio ( Selinexor ) in combination with...


The purpose of a study was to evaluate the development in the use of medications associated with an increased risk...


The purpose of the study was to describe the prevalence, clinical presentation, and management of rheumatic immune‐related adverse effects (...


Inflammation plays a considerable role in the progression of Duchenne muscular dystrophy ( DMD ), a severe muscle disease caused...


Fumaric acid esters, which are prescribed for the treatment of psoriasis and multiple sclerosis, are considered to have a favorable...


Patients receiving Dimethyl fumarate ( DMF ) are at risk for opportunistic infections even without severe lymphocytopenia. An additional patient with...


The 2015 ESC Guidelines on the diagnosis and management of pericardial diseases are published in European Heart Journal. Previous ESC...


Immunotherapies stimulate the immune system with the goal of eradicating tumors, and some side effects are likely related to this...


This is an update of a Cochrane review first published in 2006. Gout is one of the most common rheumatic...


Results published in the New England Journal of Medicine ( NEJM ) and presented at the European Respiratory Society (...


Treatment with inhaled glucocorticoids in combination with long-acting bronchodilators is recommended in patients with frequent exacerbations of severe chronic obstructive...


Many patients with severe asthma require regular treatment with oral glucocorticoids despite the use of high-dose inhaled therapy. However, the...


Some patients with severe asthma have frequent exacerbations associated with persistent eosinophilic inflammation despite continuous treatment with high-dose inhaled glucocorticoids...


Results from a phase 2b dose-ranging study of Dupilumab, an investigational therapy, in adult patients with moderate-to-severe atopic dermatitis, a...


Previous therapeutic strategies for multiple sclerosis ( MS ) include the non-selective suppression of systemic immunity ( immunosuppressive agents, such...


Denosumab ( Prolia ) is a human monoclonal antibody ( IgG2 ) that targets and binds with high affinity and...


The FDA ( Food and Drug Administration ) has approved a new indication for Xgeva ( Denosumab ) for the...


Moderate-to-severe asthma remains poorly treated. Researchers have evaluated the efficacy and safety of Dupilumab ( SAR231893 / REGN668 ), a...